A request for funding made by Chris Bowles of the Molecular Genetics department to develop genetic testing for a specific type of lung cancer has been awarded a grant by local cancer charity FORCE . The test will enable patients with non-small cell lung cancer (NSCLC) to be monitored using blood tests rather than tumour biopsies by detecting circulating tumour DNA (ctDNA). This will reduce the need for unpleasant biopsy procedures, improve turnaround time for results from weeks to days and improve monitoring and targeted treatment of patients. Further details about the grant and development can be found in the Autumn 2017 FORCE newsletter.
